Title |
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non‐ST segment elevation acute coronary syndromes
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2013
|
DOI | 10.1002/14651858.cd002130.pub4 |
Pubmed ID | |
Authors |
Xavier Bosch, Jaume Marrugat, Juan Sanchis |
Abstract |
During percutaneous coronary intervention (PCI), and in non-ST segment elevation acute coronary syndromes (NSTEACS), the risk of acute vessel occlusion by thrombosis is high. Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may prevent mortality and myocardial infarction. This is an update of a Cochrane review first published in 2001, and previously updated in 2007 and 2010. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | <1% |
Unknown | 103 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 12% |
Student > Master | 12 | 12% |
Student > Bachelor | 11 | 11% |
Other | 8 | 8% |
Student > Ph. D. Student | 7 | 7% |
Other | 14 | 13% |
Unknown | 40 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 38% |
Nursing and Health Professions | 9 | 9% |
Environmental Science | 3 | 3% |
Psychology | 3 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 2% |
Other | 7 | 7% |
Unknown | 41 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2020.
All research outputs
#16,106,935
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,216
of 11,842 outputs
Outputs of similar age
#131,626
of 229,311 outputs
Outputs of similar age from Cochrane database of systematic reviews
#218
of 245 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,311 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 245 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.